Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access atrial fibrillation specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation treatment provided free
A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy.
Sponsor: Anthos Therapeutics, Inc.
Check if you qualify for this atrial fibrillation clinical trial in Phoenix, AZ
If you're searching for atrial fibrillation treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.